Back to Search
Start Over
Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study.
- Source :
-
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Feb 01; Vol. 35, pp. 10205. Date of Electronic Publication: 2022 Feb 01 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Data from the general population suggest that fatality rates declined during the course of the pandemic. This analysis, using data extracted from the Brazilian Kidney Transplant COVID-19 Registry, seeks to determine fatality rates over time since the index case on March 3rd, 2020. Data from hospitalized patients with RT-PCR positive SARS-CoV-2 infection from March to August 2020 (35 sites, 878 patients) were compared using trend tests according to quartiles (Q1: <72 days; Q2: 72-104 days; Q3: 105-140 days; Q4: >140 days after the index case). The 28-day fatality decreased from 29.5% (Q1) to 18.8% (Q4) ( p <subscript> for-trend </subscript> = 0.004). In multivariable analysis, patients diagnosed in Q4 showed a 35% reduced risk of death. The trend of reducing fatality was associated with a lower number of comorbidities (20.7-10.6%, p <subscript> for-trend </subscript> = 0.002), younger age (55-53 years, p <subscript> for-trend </subscript> = 0.062), and better baseline renal function (43.6-47.7 ml/min/1.73 m <superscript>2</superscript> , p <subscript> for-trend </subscript> = 0.060), and were confirmed by multivariable analysis. The proportion of patients presenting dyspnea ( p <subscript> for-trend </subscript> = 0.001) and hypoxemia ( p <subscript> for-trend </subscript> < 0.001) at diagnosis, and requiring intensive care was also found reduced ( p <subscript> for-trend </subscript> = 0.038). Despite possible confounding variables and time-dependent sampling differences, we conclude that COVID-19-associated fatality decreased over time. Differences in demographics, clinical presentation, and treatment options might be involved.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Sandes-Freitas, Cristelli, Requião-Moura, Modelli de Andrade, Viana, Garcia, de Oliveira, Esmeraldo, de Lima, Charpiot, Ferreira, Franco, Costa, Simão, Ferreira, Santana, Almeida, Deboni, Saldanha, Noronha, Oliveira, Carvalho, Oriá, Medina-Pestana and Tedesco-Silva Junior.)
Details
- Language :
- English
- ISSN :
- 1432-2277
- Volume :
- 35
- Database :
- MEDLINE
- Journal :
- Transplant international : official journal of the European Society for Organ Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 35185380
- Full Text :
- https://doi.org/10.3389/ti.2022.10205